Titan Medical Inc.

Titan Medical Inc.

TMDIF
Titan Medical Inc.US flagOther OTC
0.82
USD
+0.78
- -
13.91MMarket Cap
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.3
0.19
- -
0.16
0.01
Basic EPS, GAAP
-8.73
-3.65
-3.75
-4.29
-11.92
-4.77
-4.25
-1.36
-1.37
-0.36
-0.14
-0.38
0.06
-0.04
Free Cash Flow per Basic Share
-8.45
-3.68
-3.31
-4.33
-9.91
-7.24
-2.44
-2.51
-1.51
-0.02
-0.34
-0.26
0.04
-0.06
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.33
-2.18
-3.52
6.74
-2.1
-0.81
0.47
-0.15
-0.65
-0.36
0.09
-0.29
-0.21
-0.22
Tangible Book Value per Share
4.95
1.95
0.76
9.34
-0.25
- -
1.12
0.18
-0.43
-0.23
0.31
-0.05
0.04
0.02
Basic Weighted Avg Shares
2
2
2
3
3
5
8
17
31
67
108
112
113
114
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
20
20
- -
18
1
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
20.76
-153.86
- -
50.75
-240.53
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
- -
- -
Net Income, GAAP
-16
-8
-9
-13
-41
-23
-34
-23
-42
-24
-15
-43
7
-5
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.34
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-120.92
-73.95
- -
39.43
-531.26
Working Capital
9
4
2
29
-1
- -
9
3
-13
-16
33
-4
6
3
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
1
Total Equity
9
4
2
30
- -
1
10
4
-12
-14
35
-3
5
3
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
381.36
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-27.44
-1.52
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
3.93

Capital Structure

FRC

in mil. unless spec.
Dec'23
Mar'24
Jun'24
ST Debt
- -
- -
1
LT Borrowings
- -
- -
- -
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
114
114
114
Market Capitalization
173
146
114

Working Capital

FRC

in mil. unless spec.
Dec'23
Mar'24
Jun'24
Total Current Assets
9
7
4
Cash, Cash Equivalents & STI
8
6
4
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
3
2
1
Payables & Accruals
3
2
1
ST Debt
- -
- -
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
140.52%
-214.91%
-251.23%
Free Cash Flow
256.56%
452.62%
-115.62%
Net Income, GAAP
30.3%
14.85%
-116.34%
Sales/Revenue/Turnover
- -
- -
-12.25%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
17
- -
- -
18
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-0.08
-0.1
-0.09
- -
-0.38
2023
-0.02
0.12
- -
- -
0.06
2024
-0.01
-0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Thomas Looby
Full Time Employees
4
Sector
Healthcare
Industry
Medical - Devices
Address
76 Berkeley Street Toronto ON Canada M5A 2W7
IPO Date
Jan 5, 2010
Business
Conavi Medical Corp., formerly known as Titan Medical Inc., functions as a medical technology enterprise. The company now specializes in advanced cardiovascular imaging systems, following its recent business combination, having previously focused on developing and licensing intellectual property for robotic-assisted surgical technologies. It maintains its corporate base in Toronto, Canada.

Company News

APIChatGPT
  • Titan Medical (NASDAQ:TMDIF) Trading Down 1.7% – Should You Sell?

  • Titan Medical Group Launches Titan Workforce Solutions: Launches to Transform Healthcare Staffing

  • Titan Nurse Staffing, LLC and Titan Medical Group, LLC Announce Merger to Streamline Healthcare Staffing Services

  • Conavi Medical Corp. (formerly “Titan Medical Inc.”) Completes Business Combination

  • Titan Announces the Closing of Conavi's Private Placement of Subscription Receipts and Provides Update on the Transaction

  • Titan Announces Resignations of Directors

  • Titan Reports Voting Results from 2023 Annual General and Special Meeting

  • Titan Medical begins process to move to the TSX Venture Exchange

  • Conavi Medical Shareholders Approve the Proposed Amalgamation Between Titan and Conavi

  • Proxy Deadline Thursday September 26, 2024

  • Proxy Advisor Glass, Lewis & Co., Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi

  • Titan Announces Conavi Medical to Present Overview at Titan Q&A Session

  • Independent Proxy Advisor, Institutional Shareholder Services (“ISS”), Recommends Titan Shareholders Vote FOR the Amalgamation Between Titan and Conavi

  • Titan Announces Q&A Session with Shareholders

  • Titan Announces Filing of the Management Information Circular.

  • Titan Medical Reports Operating and Financial Results for the Second Quarter 2024

  • Titan Further Amends Amalgamation Agreement with Conavi Medical Inc. and Announces Further Extension of 2024 Annual General and Special Meeting

  • Titan Amends Amalgamation Agreement with Conavi Medical Inc.

  • Titan Amends Amalgamation Agreement with Conavi Medical Inc. and Announces Extension of 2023 Annual General and Special Meeting

  • Titan Provides Update on Planned Merger with Conavi